If someone has avoided making lifestyle changes before, some doctors might wait to prescribe GLP-1 until theres stronger motivation
Pyrls Post The FLOW trial for semaglutide kidney outcomes in T2DM halted due to interim results meeting efficacy criteria FLOW is a RCT comparing injectable semaglutide 1.0 mg with placebo as an adjunct to standard of care on kidney outcomes in people with type 2 diabetes and chronic kidney disease
The advantage of tuberculin syringes is precision in milliliter measurements
GLP-1 medications (you know them as Ozempic, Wegovy, Zepbound, and more) have quickly become tools for helping people with obesity and diabetes lose large amounts of weight when diet and exercise havent worked
If you have type 2 diabetes and have been diagnosed with heart disease or chronic kidney disease, this update is worth raising with your doctor or endocrinologist at your next appointment
Our Liposomal Glutathione is designed specifically with this in mind